Isturisa (osilodrostat)

pCPA File Number: 23447
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of adult patients with Cushing’s disease who have persistent or recurrent hypercortisolism after primary pituitary surgery and/or irradiation, or for whom pituitary surgery is not an option.
Sponsor/Manufacturer:
Recordati Rare Diseases Canada Inc.
CDA-AMC Project Number:
SR0804-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable